Remicade and Hepatosplenic t-cell lymphoma - from FDA reports


Summary

Hepatosplenic t-cell lymphoma is found among people who take Remicade, especially for people who are male, 20-29 old , have been taking the drug for 2 - 5 years, also take medication Mercaptopurine, and have Crohn's disease. This review analyzes which people have Hepatosplenic t-cell lymphoma with Remicade. It is created by eHealthMe based on reports of 124,285 people who have side effects when taking Remicade from FDA, and is updated regularly.

What to expect?

If you take Remicade and have Hepatosplenic t-cell lymphoma, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Remicade and have Hepatosplenic t-cell lymphoma

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On May, 09, 2017

124,285 people reported to have side effects when taking Remicade.
Among them, 299 people (0.24%) have Hepatosplenic T-cell Lymphoma


Number of reports submitted per year:

Could Remicade cause Hepatosplenic t-cell lymphoma?

Time on Remicade when people have Hepatosplenic T-cell Lymphoma *:

  • < 1 month: 19.7 %
  • 1 - 6 months: 28.79 %
  • 6 - 12 months: 4.55 %
  • 1 - 2 years: 1.52 %
  • 2 - 5 years: 43.94 %
  • 5 - 10 years: 1.52 %
  • 10+ years: 0.0 %

Gender of people who have Hepatosplenic T-cell Lymphoma when taking Remicade *:

  • female: 14.49 %
  • male: 85.51 %

Age of people who have Hepatosplenic T-cell Lymphoma when taking Remicade *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 24.89 %
  • 20-29: 33.94 %
  • 30-39: 25.79 %
  • 40-49: 1.36 %
  • 50-59: 9.05 %
  • 60+: 4.98 %

Top conditions involved for these people *:

  • Crohn's Disease (230 people, 76.92%)
  • Ulcerative Colitis (49 people, 16.39%)
  • Inflammatory Bowel Disease (15 people, 5.02%)
  • Diarrhea (11 people, 3.68%)
  • Colitis (10 people, 3.34%)

Top co-used drugs for these people *:

  • Mercaptopurine (105 people, 35.12%)
  • Azathioprine (93 people, 31.10%)
  • Imuran (60 people, 20.07%)
  • Asacol (56 people, 18.73%)
  • Humira (46 people, 15.38%)

Top other side effects for these people *:

  • Thrombocytopenia (38 people, 12.71%)
  • Drug Ineffective (32 people, 10.70%)
  • Sepsis (31 people, 10.37%)
  • Leukopenia (31 people, 10.37%)
  • Fever (28 people, 9.36%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Hepatosplenic t-cell lymphoma when taking Remicade?

Remicade

Remicade has active ingredients of infliximab. It is often used in crohn's disease. (latest outcomes from Remicade 125,347 users)

Hepatosplenic T-cell Lymphoma

Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow) has been reported by people with crohn's disease, ulcerative colitis, inflammatory bowel disease, rheumatoid arthritis, juvenile rheumatoid arthritis (latest reports from 475 Hepatosplenic t-cell lymphoma patients).

Browse all side effects of Remicade

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Hepatosplenic t-cell lymphoma

Hepatosplenic t-cell lymphoma

Could your condition cause Hepatosplenic t-cell lymphoma

Hepatosplenic t-cell lymphoma

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Remicade and have Hepatosplenic t-cell lymphoma.

Can you answer these questions?

More questions for: Remicade, Hepatosplenic t-cell lymphoma

You may be interested in these reviews

More reviews for: Remicade, Hepatosplenic t-cell lymphoma